Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
The Montgomery Advertiser on MSN3d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
3don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
One potential solution is HIV self-testing, which would allow for rapid identification and treatment. Identifying HIV cases is the first step in addressing clusters, and quickly learning one’s ...
Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.
In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback